PTC
CELG

Peak Ten Capital’s Celgene Corp CELG Stock Holding History

Peak Ten Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$433K Buy
+4,000
New +$496K 0.93% 27
2015
Q1 		– Sell
-10,000
Closed -$1.12M – 64
2014
Q4 		$1.12M Buy
+10,000
New +$1.05M 1.1% 40

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Peak Ten Capital's CELG Position: Q3 2015 in Review

Peak Ten Capital opened a new position in Celgene Corp (CELG) in Q3 2015: 4,000 shares worth $433K. The stake represents 0.93% of the portfolio and ranks #27 among its holdings. This is a return to the name: Peak Ten Capital previously reported a position in CELG as recently as Q4 2014.

Peak Ten Capital first reported a position in CELG in Q4 2014 and has held it in 2 quarters since. The position peaked at $1.12M in Q4 2014. 1,195 funds tracked by Wall St. Rank hold CELG as of Q3 2015.

  • Peak Ten Capital held 4,000 shares of Celgene Corp worth $433K as of Q3 2015.
  • Celgene Corp was a new Peak Ten Capital position in Q3 2015.
  • Celgene Corp made up 0.93% of Peak Ten Capital's portfolio in Q3 2015, its #27 holding.
  • Peak Ten Capital first reported a position in Celgene Corp in Q4 2014 and has held it in 2 quarters since.
  • Peak Ten Capital's Celgene Corp position peaked at $1.12M in Q4 2014.
  • 1,195 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2015.

Based on Peak Ten Capital's 13F filing for Q3 2015, filed 16 Nov 2015.